neurodex - Meet the Neurodex Team Discover the auxillary experienced professionals behind Neurodex39s innovative research in neurodegenerative diseases including Who we are Neurodex Nov 7 2024 NeuroDex secures Target ALS Biomarker Consortia Grant to advance ALS diagnosis with innovative bloodbased biomarkers Neurodex specializes in developing EVbased blood biomarkers to select patients and monitor treatment response in clinical trials We offer Biomarker Discovery Services for neurology using advanced EV technologies to deliver accurate and reliable results Our board members and advisers Neurodex Biomarker Discovery Services Neurodex NeuroDex is developing a suite of bloodbased biomarkers that can identify patients with synucleinopathies even in the context of different forms of dementia This technology relies on NeuroDexs recent advances in isolating cellspecific extracellular vesicles exosomes from plasma and detecting protein markers of disease in the contents Misfolding accumulation and synuclein aggregation are major hallmarks of Parkinsons disease and Lewy body dementia Neurodexs Exosort and LuminEV allow measurements of synuclein pathology specific to neurons via assessment of αSyn accumulation and aggregation inside NDEs or on their surface Mar 28 2023 NeuroDex Inc NeuroDex or the kode scarlett Company announces that it has received an investment from the Alzheimers Drug Discovery Foundation ADDF for Clinical Validation of a Robust Blood Test Using NeuronDerived Exosomes for Detection of AlphaSynucleinTDP43 Pathologies in Patients with Alzheimers Disease through the ADDF Our team Neurodex Jul 25 2024 Rather than a onesizefitsall blood test that looks for a single pathology NeuroDex is commercializing a novel scientific approach based on the study of extracellular vesicles that can decipher mixed pathology in dementia and lead to a more personalized treatment plan As a pioneer in the field Dr Eitan has developed novel methodologies and published over 27 peer reviewed articles Prior to founding NeuroDex Dr Eitan served as senior scientist in a leading diagnostic company Dr Eitan has led research collaborations with several pharmaceutical companies as well as academia Home Page Neurodex Neurodex News Archives Neurodex Contact us NeuroDex Inc 27 Strathmore road Natick MA US 01760 infoneurodexco Our tech Our Publications Collaboration Biotech Blog NeuroDex Awarded Target ALS Our Tech Neurodex NeuroDex Inc Announces Award qontak login from Alzheimers Drug Discovery
ngedown
lama permainan sepak bola tiap babaknya adalah
